{"id":"W2800630992","doi":"10.1016/j.ctrv.2018.04.014","title":"The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Amgen","keywords":"Denosumab; Medicine; Cabazitaxel; Enzalutamide; Abiraterone acetate; Prostate cancer; Radium-223; Zoledronic acid; Oncology; Clinical trial; Docetaxel; Internal medicine; Bisphosphonate; Osteonecrosis of the jaw; Cancer; Osteoporosis; Bone metastasis; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000374636,0.0005155046,0.003341876,0.0000603175,0.00007823177,0.000005543305,0.0002580772,0.0001723635,0.0001449276],"category_scores_gemma":[0.00009846208,0.0001814119,0.0009784553,0.0004923041,0.0002085533,0.0000299075,0.00004041775,0.0001167056,0.00000554395],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007959016,"about_ca_system_score_gemma":0.003440623,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007106569,"about_ca_topic_score_gemma":0.00894656,"domain_scores_codex":[0.9970464,0.0002163971,0.001745825,0.0004267827,0.0002079294,0.0003566815],"domain_scores_gemma":[0.9966249,0.0002903943,0.001781757,0.0010283,0.0001633793,0.0001113026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003638059,0.0003267576,0.006634845,0.02320707,0.0006620553,4.557935e-7,0.000541828,4.109341e-8,0.000001138193,0.00001442452,0.00104517,0.9672024],"study_design_scores_gemma":[0.001637229,0.000765515,0.0004030535,0.03184849,0.002644949,0.000002837427,0.00002184525,5.001652e-7,0.0005293079,0.00007641355,0.9619508,0.000119018],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000245635,0.9869084,1.813699e-7,0.0002927941,0.0002695538,0.01178104,0.0003131099,0.000006320296,0.0001829203],"genre_scores_gemma":[0.00005706535,0.9864556,0.0001195727,0.00003325533,0.00006059833,0.005991103,0.0000274446,0.00004753968,0.007207778],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9670834,"threshold_uncertainty_score":0.9995052,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08337314094360428,"score_gpt":0.4118292651315053,"score_spread":0.328456124187901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}